GR3024670T3 - Induction of protection against viral infection - Google Patents

Induction of protection against viral infection

Info

Publication number: GR3024670T3
Authority: GR; Greece
Prior art keywords: virus; induction; antibodies; protection against; viral infection
Prior art date: 1990-03-19

Application number

GR970402313T

Other languages

English (en)

Inventor

Marc Girard

Marie-Paule Kieny

Claude Leclerc

Original Assignee

Pasteur Institut

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-03-19

Filing date

1997-09-10

Publication date

1997-12-31

1997-09-10 Application filed by Pasteur Institut filed Critical Pasteur Institut

1997-12-31 Publication of GR3024670T3 publication Critical patent/GR3024670T3/el

Links

208000036142 Viral infection Diseases 0.000 title 1
230000006698 induction Effects 0.000 title 1
230000009385 viral infection Effects 0.000 title 1
101710121417 Envelope glycoprotein Proteins 0.000 abstract 2
102100021696 Syncytin-1 Human genes 0.000 abstract 2
241000700605 Viruses Species 0.000 abstract 2
230000003472 neutralizing effect Effects 0.000 abstract 2
108090000765 processed proteins & peptides Proteins 0.000 abstract 2
108090000288 Glycoproteins Proteins 0.000 abstract 1
102000003886 Glycoproteins Human genes 0.000 abstract 1
230000010530 Virus Neutralization Effects 0.000 abstract 1
125000003275 alpha amino acid group Chemical group 0.000 abstract 1
235000001014 amino acid Nutrition 0.000 abstract 1
150000001413 amino acids Chemical class 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000012634 fragment Substances 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Virology (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

GR970402313T 1990-03-19 1997-09-10 Induction of protection against viral infection GR3024670T3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US49474990A	1990-03-19	1990-03-19
PCT/EP1991/000509 WO1991014449A1 (en)	1990-03-19	1991-03-16	Induction of protection against viral infection

Publications (1)

Publication Number	Publication Date
GR3024670T3 true GR3024670T3 (en)	1997-12-31

Family

ID=23965805

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR970402313T GR3024670T3 (en)	1990-03-19	1997-09-10	Induction of protection against viral infection

Country Status (10)

Country	Link
EP (2)	EP0472706B1 (el)
JP (2)	JPH03271233A (el)
AT (1)	ATE154244T1 (el)
AU (3)	AU651816B2 (el)
CA (1)	CA2057040A1 (el)
DE (1)	DE69126486T2 (el)
DK (1)	DK0472706T3 (el)
ES (1)	ES2104695T3 (el)
GR (1)	GR3024670T3 (el)
WO (1)	WO1991014449A1 (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5976541A (en) *	1988-01-26	1999-11-02	The United States Of America As Represented By The Department Of Health And Human Services	Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope
US5876724A (en) *	1990-03-19	1999-03-02	Institut Pasteur	Induction of neutralizing antibody against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein
US6139843A (en) *	1991-04-02	2000-10-31	Albert Einstein College Of Medicine Of Yeshiva University	Peptide compositions for the treatment of HIV
EP0536352B1 (en) *	1991-04-02	2003-12-17	Albert Einstein College Of Medicine Of Yeshiva University	Therapeutic and preventive vaccines for hiv
EP0613378A1 (en) *	1991-10-28	1994-09-07	Institut Pasteur	Induction of protection against viral infection by synergy between viral proteins and viral peptides
FR2692898B1 (fr) *	1992-06-30	1995-06-02	Centre Nat Rech Scient	Procédé d'obtention de protéines membranaires, et utilisation de ces protéines dans un but de diagnostic ou de vaccination.
UA68327C2 (en)	1995-07-04	2004-08-16	Gsf Forschungszentrum Fur Unwe	A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals
MX428176B (es) *	2019-01-28	2025-11-13	Xyphos Biosciences Inc	Ligandos nkg2d no naturales modificados que entregan selectivamente moléculas heterólogas unidas a receptores nkg2d no naturales en células car.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2054616T3 (es) *	1985-12-17	1994-08-16	Akzo Nv	Reactivo inmunoquimico.
NZ221440A (en) *	1986-08-20	1991-11-26	Genetic Systems Corp	Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
DE3854550T2 (de) *	1987-11-24	1996-04-25	Abbott Lab	HIV-Peptide und Methoden für den Nachweis von HIV.
US5039522A (en) *	1988-01-29	1991-08-13	New York Blood Center, Inc.	Immunogens containing peptides with an attached hydrophobic tail for adsorption to hepatitis B virus surface antigen
CA1341285C (en) *	1988-02-12	2001-08-14	Chang Yi Wang	Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
FR2650954B1 (fr) *	1989-08-18	1992-02-28	Pasteur Institut	Composition resultant de la reunion d'un epitope b de la glycoproteine d'enveloppe d'un retrovirus du type iv et d'un epitope t issu d'une proteine distincte codee par ce retrovirus et leur application a la production d'anticorps protecteurs contre le sida

1990
- 1990-11-30 JP JP2341189A patent/JPH03271233A/ja active Pending
1991
- 1991-03-16 CA CA002057040A patent/CA2057040A1/en not_active Abandoned
- 1991-03-16 EP EP91906386A patent/EP0472706B1/en not_active Expired - Lifetime
- 1991-03-16 DK DK91906386.7T patent/DK0472706T3/da active
- 1991-03-16 AT AT91906386T patent/ATE154244T1/de not_active IP Right Cessation
- 1991-03-16 WO PCT/EP1991/000509 patent/WO1991014449A1/en not_active Ceased
- 1991-03-16 DE DE69126486T patent/DE69126486T2/de not_active Expired - Fee Related
- 1991-03-16 JP JP3506292A patent/JPH04506220A/ja active Pending
- 1991-03-16 ES ES91906386T patent/ES2104695T3/es not_active Expired - Lifetime
- 1991-03-16 EP EP96106172A patent/EP0742229A3/en not_active Withdrawn
- 1991-03-16 AU AU74989/91A patent/AU651816B2/en not_active Ceased
1994
- 1994-06-09 AU AU64615/94A patent/AU6461594A/en not_active Abandoned
1997
- 1997-09-10 GR GR970402313T patent/GR3024670T3/el unknown
1998
- 1998-06-16 AU AU71960/98A patent/AU7196098A/en not_active Abandoned

Also Published As

Publication number	Publication date
EP0472706B1 (en)	1997-06-11
EP0742229A3 (en)	1998-06-03
ES2104695T3 (es)	1997-10-16
CA2057040A1 (en)	1991-09-20
JPH03271233A (ja)	1991-12-03
EP0742229A2 (en)	1996-11-13
EP0472706A1 (en)	1992-03-04
AU7498991A (en)	1991-10-21
DK0472706T3 (da)	1997-12-29
AU6461594A (en)	1994-09-08
AU7196098A (en)	1998-08-13
ATE154244T1 (de)	1997-06-15
WO1991014449A1 (en)	1991-10-03
DE69126486D1 (de)	1997-07-17
DE69126486T2 (de)	1998-01-15
AU651816B2 (en)	1994-08-04
JPH04506220A (ja)	1992-10-29

Publication	Publication Date	Title
EP0090581A3 (en)	1984-10-24	Small peptides with the specificity of foot and mouth disease viral antigens
PT835133E (pt)	2008-11-19	Composições recombinantes de poxvírus-raiva e composições de combinação e suas utilizações
GR3024274T3 (en)	1997-10-31	Anti cd-4 antibodies blocking hiv-induced syncytia
CA2193210A1 (en)	1995-12-07	Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen
RU95122391A (ru)	1998-02-10	Адъюванты для вакцины против распираторно-синцитиального вируса
NZ503763A (en)	2003-01-31	Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
CA2091263A1 (en)	1992-03-28	Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
EP0866133A3 (en)	2001-09-26	A group b streptococcus vaccine
DK0835315T3 (da)	2009-08-17	Vaccine til porcint reproduktivt og respiratorisk syndrom virus
WO1999064603A3 (en)	2000-02-10	ENHANCEMENT OF B CELL ACTIVATION AND IMMUNOGLOBULIN SECRETION BY CO-STIMULATION OF RECEPTORS FOR ANTIGEN AND EBV Gp350/220
GR3029264T3 (en)	1999-05-28	Anti-feline immunodeficiency virus (fiv) vaccines.
AU7196098A (en)	1998-08-13	Induction of protection against viral infection
DE69534617D1 (en)	2005-12-22	Hepatitis b-impfstoff
GR3032134T3 (en)	2000-04-27	Vaccine compositions
DE69626642D1 (de)	2003-04-17	Cetp zur erhöhung des hdl-cholesterol-gehalts
DK0439601T3 (da)	1994-06-13	Præparat indeholdende en B-epitop fra kappe- glycoproteinet fra et retrovirus og en T-epitop fra et protein, der er forskelligt fra dette retrovirus
EP0655072A4 (en)	1997-03-19	EQUINE HERPESVIRUS GLYCOPROTEINS.
GB9820002D0 (en)	1998-11-04	Novel compounds
CA2079230A1 (en)	1991-09-27	Bcrf1 antagonists for treating epstein-barr virus infections
SE9600436D0 (sv)	1996-02-06	Vaccine against hantavirus
KR950701821A (ko)	1995-05-17	피임 백신(contraceptive vaccine)
WO2000018429A3 (en)	2000-07-06	Vaccine based on attenuated $i(haemophilus somnus)
EP0556388A1 (en)	1993-08-25	Antiviral agent
KR970074790A (ko)	1997-12-10	합성 펩티드를 함유하는 녹농균 백신 및 이것으로부터 생산된 치료제
RU93004854A (ru)	1995-12-27	Пептиды для вакцинации и индукции нейтрализующих антител против вируса иммунодефицита человека